Hyperthermic Intraperitoneal Chemotherapy with Melphalan: A Summary of Clinical and Pharmacological Data in 34 Patients

Table 1

Demographic and perioperative data on 34 patients treated with cytoreductive surgery and heated intraperitoneal chemotherapy with melphalan.

Gender
Male	14
Female	20
Age (mean)	46.1
Primary diagnosis
Appendix cancer	23
Mesothelioma	6
Colon cancer	2
Ovarian cancer	2
Urachal cancer	1
Peritoneal cancer index (PCI)
Mean	21
Range	4–39
Completeness of cytoreduction score
CC-1	21
CC-2	7
CC-3	6
Dose of melphalan
50 mg/m^2	5
60 mg/m^2	17
70 mg/m^2	10